Domov › Srčno popuščanje › Georgia › Atlanta
Klinične študije za Srčno popuščanje v Atlanta, GA
25 študij za Srčno popuščanje išče udeležence na lokacijah v Atlanta in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
ELEVATE-HFpEF Clinical Study
Vključevanje udeležencev
- Emory University, Atlanta
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Vključevanje udeležencevFaza 3
- Research Site, Atlanta
- Research Site, Atlanta
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Vključevanje udeležencevFaza 3
- Atlanta Clinical Research Centers, Atlanta
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Vključevanje udeležencevFaza 3
- Atlanta Clinical Research Centers, Atlanta
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Vključevanje udeležencevFaza 3
- Research Site, Atlanta
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Vključevanje udeležencevFaza 3
- Grady Health System, Atlanta
- Piedmont Atlanta Hospital, Atlanta
- Emory Clinic, Atlanta
Alleviant ALLAY-HFrEF Study
Vključevanje udeležencev
- Atlanta VA Health Care System, Decatur · 6 mi stran
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Vključevanje udeležencevFaza 3
- Piedmont Heart Institute, Atlanta
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Vključevanje udeležencevFaza 3
- Research Site, Atlanta
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Vključevanje udeležencevFaza 3
- CON-10022 Atlanta, GA Investigational Site, Atlanta
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Vključevanje udeležencevFaza 3
- Atlanta, GA Investigative Site 10022, Atlanta
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Vključevanje udeležencev
- Piedmont Healthcare, Atlanta
- Emory University, Atlanta
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
Vključevanje udeležencev
- Piedmont Hospital, Atlanta
- Emory University Hospital, Atlanta
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Vključevanje udeležencevFaza 2/3
- Children's Healthcare of Atlanta - Arthur M. Blank Hospital ( Site 0001), Atlanta
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Vključevanje udeležencev
- Emory University Hospital, Atlanta
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Vključevanje udeležencevOpazovalna študija
- Atlanta, Atlanta
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Vključevanje udeležencevFaza 3
- Tenax Investigational Site, Atlanta
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Vključevanje udeležencevFaza 3
- Atlanta Center for Clinical Research_Atlanta, Atlanta
- East Atlanta Cardiology, Conyers · 22 mi stran
- Hope Clin Res & Wellness, Conyers · 22 mi stran
Alleviant ALLAY-HF Study
Vključevanje udeležencev
- Atlanta VA Health Care System, Decatur · 6 mi stran
CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
Vključevanje udeležencev
- Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur · 6 mi stran
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Vključevanje udeležencevFaza 3
- Emory University Hospital - Children's Healthcare of Atlanta Cardiology - Atlanta, Atlanta
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Vključevanje udeležencev
- Piedmont, Atlanta
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Vključevanje udeležencevFaza 3
- Emory University Hospital - Children's Healthcare of Atlanta Cardiology - Atlanta, Atlanta
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Vključevanje udeležencev
- Piedmont Heart Institute, Atlanta
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Vključevanje udeležencev
- Emory University Hospital, Atlanta
Študije za Srčno popuščanje v drugih mestih
- New York City, NY51 študij
- Boston, MA44 študij
- Dallas, TX42 študij
- Houston, TX36 študij
- Cleveland, OH33 študij
- Chicago, IL31 študij
- Philadelphia, PA31 študij
- San Francisco, CA29 študij
- St. Louis, MO26 študij
- Durham, NC26 študij
- Kansas City, MO25 študij
- Baltimore, MD24 študij
Druge študije v Atlanta
- Rak (vse vrste)49 študij
- Nemalicelični pljučni rak47 študij
- Rak dojke41 študij
- Množni mielom41 študij
- Rak prostate33 študij
- Akutna mieločna levkemija30 študij
- Rak jajčnikov29 študij
- Rak pljuč29 študij
- Kolorektalni rak29 študij
- Metastatski rak28 študij
- Velika depresivna motnja25 študij
- Ploščatocelični karcinom glave in vratu24 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.